View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
HHS/FDA RIN: 0910-AG78 Publication ID: Fall 2011 
Title: ●Effective Date of Requirement for Premarket Approval for Two Class III Preamendments Devices 
Abstract: The Food and Drug Administration is proposing to require the filing of a premarket approval application (PMA) or a notice of completion of a product development protocol (PDP) for the following two class III preamendments devices: hip joint metal/metal semi-constrained, with an uncemented acetabular component, prosthesis. 
Agency: Department of Health and Human Services(HHS)  Priority: Economically Significant 
RIN Status: First time published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: Yes  Unfunded Mandates: No 
CFR Citation: 21 CFR 888.3320    21 CFR 888.3330   
Legal Authority: 21 USC 360e(b)(1)    sec 515(b)(1) of the Federal Food, Drug, and Cosmetic Act   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  05/00/2012    
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Michael Ryan
Regulatory Advisor
Department of Health and Human Services
Food and Drug Administration
White Oak, Building 66, Room 1615, 10903 New Hampshire Avenue,
Silver Spring, MD 20993
Phone:301 796-6283
Email: michael.ryan@fda.hhs.gov